Diseases, Conditions, Syndromes

Patients underestimate risk of deep vein thrombosis, say researchers

(Medical Xpress)—Many people going into hospital have concerns about contracting the hospital acquired infection MRSA, yet the risk of acquiring - and dying from – hospital acquired venous thromboembolism (VTE) is much ...

Oncology & Cancer

Unsuspected PE does not up mortality risk in cancer patients

(HealthDay) -- Cancer patients with an unsuspected pulmonary embolism (UPE) do not have an increased mortality risk and have a similar risk of recurrent venous thromboembolism (VTE) to those with clinically suspected pulmonary ...

Diseases, Conditions, Syndromes

Long-term mortality risk low after cerebral vein thrombosis

(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in the July issue of the ...

Diseases, Conditions, Syndromes

Marker helps predict thrombotic risk of hormonal contraceptives

(HealthDay) -- For women taking hormonal contraceptives, sex hormone-binding globulin (SHBG) is a useful marker to estimate the risk of venous thrombosis, according to research published in the June issue of the Journal of ...

Diseases, Conditions, Syndromes

Higher risk of VTE in CKD surgical patients on enoxaparin

(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those ...

Obstetrics & gynaecology

Study adds to evidence on clot risks of non-oral contraceptives

A study published on BMJ website today adds to the evidence that certain non-oral hormonal contraceptives (e.g. skin patches, implants and vaginal rings) carry a higher risk of serious blood clots (known as venous thromboembolism) ...

Oncology & Cancer

Prophylaxis with apixaban feasible for cancer patients

(HealthDay) -- Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is ...

Diseases, Conditions, Syndromes

New guidelines developed for improved deep venous thrombosis diagnosis

A researcher at Intermountain Medical Center in Salt Lake City is part of a select panel of international experts to help develop new evidence-based clinical guidelines used by physicians worldwide for the diagnosis and treatment ...

page 8 from 10